Breast Cancer Awareness Month: A Panel Discussion with Christine Samuel, Mikel Ross, and Lillie Shockney

In this recording of Oncology Data Advisor's Live Breast Cancer Panel, three noted experts partake in a conversation about recent advances in treatment, strategies and integrative medicine modalities to minimize toxicity, and techniques for delivering patient-centered care.

Continue reading

Oncology Nurses’ Educational Needs: CDK4/6 Inhibitors

​Cyclin dependent kinase (CDK)4/6 inhibitors have produced tremendous advances in the treatment of hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer through their targeting of hormone signals that stimulate the proliferation of cancer cells. Three CDK4/6 inhibitors have been FDA approved for the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer: palbociclib (Ibrance®, Pfizer Inc.), ribociclib (Kisqali®, Novar...
Continue reading

Overcoming Challenges in Nursing Management of Metastatic Breast Cancer With Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN®

Metastatic breast cancer (MBC) is associated with a poor prognosis, and patients often develop refractory or resistant disease, adverse events, depression, and financial hardship. Mikel Ross, MSN, RN, AGPCNP-BC, OCN®, CBCN®, office practice nurse in the Outpatient Breast Medicine Service at Memorial Sloan Kettering Cancer Center, spoke with i3 Health about challenging patient questions and the importance of multidisciplinary care in the management of patients with MBC. What are some of the most ...
Continue reading

Subscribe

Get the latest updates delivered to your inbox!

Follow Us

Copyright © 2021 Oncology Data Advisor. All rights reserved.